TY - JOUR T1 - The study of risk in pulmonary arterial hypertension JF - European Respiratory Review JO - EUROPEAN RESPIRATORY REVIEW SP - 234 LP - 238 DO - 10.1183/09059180.00003712 VL - 21 IS - 125 AU - Lewis J. Rubin AU - Gerald Simonneau AU - David Badesch AU - Nazzareno Galiè AU - Marc Humbert AU - Anne Keogh AU - Joseph Massaro AU - Marco Matucci Cerinic AU - Olivier Sitbon AU - Steven Kymes Y1 - 2012/09/01 UR - http://err.ersjournals.com/content/21/125/234.abstract N2 - A growing body of published evidence exists on the risk factors for disease progression in pulmonary arterial hypertension (PAH). The Scientific Steering Committee for the Study of Risk in PAH was established to bring together leading clinical and statistical experts in PAH and risk modelling, for the purpose of advancing the understanding of the risk of development and progression of PAH. Herein, we discuss the impact of this information on three key areas: 1) clinical decision-making; 2) policy and reimbursement; and 3) future trials and research. ER -